255.77
price up icon0.05%   0.13
 
loading
Schlusskurs vom Vortag:
$255.64
Offen:
$262.54
24-Stunden-Volumen:
180.35K
Relative Volume:
0.37
Marktkapitalisierung:
$26.40B
Einnahmen:
$3.81B
Nettoeinkommen (Verlust:
$-644.79M
KGV:
-40.99
EPS:
-6.24
Netto-Cashflow:
$-669.77M
1W Leistung:
+4.44%
1M Leistung:
-6.92%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$254.37
$262.76
1-Wochen-Bereich:
Value
$246.04
$267.00
52-Wochen-Spanne:
Value
$172.67
$287.88

Beigene Ltd Adr Stock (ONC) Company Profile

Name
Firmenname
Beigene Ltd Adr
Name
Telefon
13459494123
Name
Adresse
C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN
Name
Mitarbeiter
11,000
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ONC's Discussions on Twitter

Vergleichen Sie ONC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17

Beigene Ltd Adr Stock (ONC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-07 Eingeleitet RBC Capital Mkts Outperform
2025-03-03 Hochstufung BofA Securities Neutral → Buy
2024-12-03 Fortgesetzt Morgan Stanley Overweight
2024-09-18 Eingeleitet JMP Securities Mkt Outperform
2024-02-06 Fortgesetzt JP Morgan Overweight
2023-09-12 Eingeleitet Macquarie Outperform
2023-08-17 Eingeleitet Jefferies Buy
2023-07-17 Eingeleitet Citigroup Buy
2023-06-30 Herabstufung Bernstein Outperform → Mkt Perform
2023-01-12 Eingeleitet Daiwa Securities Buy
2022-10-13 Hochstufung Guggenheim Neutral → Buy
2022-10-13 Hochstufung SVB Leerink Mkt Perform → Outperform
2022-08-09 Fortgesetzt JP Morgan Overweight
2022-03-17 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-02-07 Eingeleitet Deutsche Bank Buy
2021-10-12 Eingeleitet Bernstein Outperform
2021-10-06 Hochstufung CLSA Underperform → Buy
2021-03-08 Eingeleitet China Renaissance Buy
2021-03-01 Herabstufung CLSA Outperform → Underperform
2020-11-09 Herabstufung Ladenburg Thalmann Buy → Neutral
2020-11-06 Herabstufung Maxim Group Buy → Hold
2020-11-06 Herabstufung Piper Sandler Neutral → Underweight
Alle ansehen

Beigene Ltd Adr Aktie (ONC) Neueste Nachrichten

pulisher
Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 29, 2025

BeiGene wins US patent dispute over cancer drug - Investing.com

Apr 29, 2025
pulisher
Apr 28, 2025

BeiGene reports financial results under PRC GAAP By Investing.com - Investing.com South Africa

Apr 28, 2025
pulisher
Apr 28, 2025

BeiGene reports financial results under PRC GAAP - Investing.com

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance

Apr 24, 2025
pulisher
Apr 23, 2025

Why Summit Therapeutics Rocketed Double-Digits Today - The Motley Fool

Apr 23, 2025
pulisher
Apr 21, 2025

BigBear.ai Holdings Inc (BBAI) gets rating Downgrade from Northland Capital - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Morgan Stanley analysts upgrades an Equal-weight rating for Urban Edge Properties (UE) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

RBC Capital Mkts initates BeiGene Ltd. ADR (ONC) rating to an Outperform - knoxdaily.com

Apr 21, 2025
pulisher
Apr 17, 2025

BGNE Page Not Found - Benzinga

Apr 17, 2025
pulisher
Apr 16, 2025

Beigene’s Wang Xiaodong sells $10.1m in stock By Investing.com - Investing.com India

Apr 16, 2025
pulisher
Apr 16, 2025

Beigene’s Wang Xiaodong sells $10.1m in stock - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 10, 2025

Permian Resources Corp [PR] Director makes an insider purchase of 250,000 shares worth 3.02 million. - knoxdaily.com

Apr 10, 2025
pulisher
Apr 07, 2025

RBC Capital sets BeiGene stock Outperform with $312 target By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

RBC Capital sets BeiGene stock Outperform with $312 target - Investing.com

Apr 07, 2025
pulisher
Apr 04, 2025

JMP reiterates BeiGene stock with $348 target despite trial halt - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

Beigene’s president Wu Xiaobin sells $14.6 million in shares - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Beigene’s president Wu Xiaobin sells $14.6 million in shares By Investing.com - Investing.com India

Apr 03, 2025
pulisher
Mar 31, 2025

Macquarie Prefers Biotechs Over CDMOs; Top Picks BEIGENE/ AKESO - AASTOCKS.com

Mar 31, 2025
pulisher
Mar 20, 2025

Beigene director Wang Xiaodong sells $10.9 million in shares By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Beigene director Wang Xiaodong sells $10.9 million in shares - Investing.com India

Mar 20, 2025
pulisher
Mar 18, 2025

Beigene’s Wu Xiaobin anticipates $1.06 million from RMB shares sale - Investing.com

Mar 18, 2025
pulisher
Mar 13, 2025

Bernstein raises BeiGene stock price target to $259 - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

BeiGene CEO John Oyler sells $10 million in shares - Investing.com India

Mar 12, 2025
pulisher
Mar 08, 2025

Beigene CEO John Oyler sells $10.39 million in shares By Investing.com - Investing.com South Africa

Mar 08, 2025
pulisher
Mar 08, 2025

Beigene CEO John Oyler sells shares worth $14.6 million - Investing.com India

Mar 08, 2025
pulisher
Mar 08, 2025

BeiGene Stock: Top Executives Sell Shares Near Record High - Sharewise

Mar 08, 2025
pulisher
Mar 07, 2025

Beigene CEO John Oyler sells shares worth $14.6 million By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Beigene CEO John Oyler sells $10.39 million in shares - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

BeiGene Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Beigene chair Wang Xiaodong sells shares worth over $2 million - Investing.com India

Mar 06, 2025
pulisher
Mar 04, 2025

Beigene president sells economic interest in RMB shares for $1.16 million - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

BOCOMI: BEIGENE (06160.HK) Guides to Positive 2025 Operating Profit; Rating Kept at Buy - AASTOCKS.com

Mar 04, 2025
pulisher
Mar 03, 2025

JPMorgan maintains BeiGene stock Overweight rating, $311 target - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Beigene SVP sells $331,375 in American depositary shares By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

Beigene SVP sells $331,375 in American depositary shares - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

JPMorgan maintains BeiGene stock Overweight rating, $311 target By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

BofA lifts BeiGene stock rating, raises target to $320 - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

BofA lifts BeiGene stock rating, raises target to $320 By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 01, 2025

Beigene directors Julian and Felix Baker sell $190m in shares - Investing.com India

Mar 01, 2025
pulisher
Feb 28, 2025

BeiGene gets FDA Orphan Drug Designation for sonrotocla - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Guggenheim lifts BeiGene stock target to $348, maintains Buy rating - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Citizens JMP lifts BeiGene stock target to $348 on strong sales By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Citizens JMP lifts BeiGene stock target to $348 on strong sales - Investing.com India

Feb 28, 2025
pulisher
Feb 27, 2025

AASTOCKS Financial NewsBeiGene, Ltd. (ONC) - AASTOCKS.com

Feb 27, 2025

Finanzdaten der Beigene Ltd Adr-Aktie (ONC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Beigene Ltd Adr-Aktie (ONC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Wang Xiaodong
Chair, Scientific Advisory Brd
Apr 14 '25
Sale
242.66
41,760
10,133,595
0
$104.94
price up icon 2.45%
$259.39
price up icon 1.67%
$27.90
price up icon 13.09%
$649.67
price up icon 1.53%
$32.89
price up icon 1.26%
Kapitalisierung:     |  Volumen (24h):